Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Murati

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Medicine|September 10, 2003
A further case of acute myelomonocytic leukemia with inv(8) chromosomal rearrangement and MOZ-NCOA2 gene fusionAnne Murati, José Adélaïde, Cornel Popovici, et al.
British Journal of Haematology|April 1, 2020
Gains of EPOR and ERG genes in adult erythroleukaemiaJosé Adélaïde, Nathalie Cervera, Arnaud Guille, et al.
American Journal of Hematology|March 6, 2014
Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemiaNathalie Cervera, Raphael Itzykson, Emilie Coppin, et al.
Haematologica|October 12, 2019
Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemiasNathalie Cervera, Anne-Catherine Lhoumeau, José Adélaïde, et al.
Haematologica|February 14, 2007
New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemiasAnne Murati, José Adélaïde, Benoît Quilichini, et al.
American Journal of Hematology|September 16, 2014
Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patientsRaynier Devillier, Véronique Gelsi-Boyer, Anne Murati, et al.
American Journal of Hematology|November 18, 2017
Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasmsGeoffroy Venton, Frédéric Courtier, Aude Charbonnier, et al.
Journal of Cell Science|March 24, 2005
NACA is a positive regulator of human erythroid-cell differentiationSophie Lopez, Laetitia Stuhl, Serge Fichelson, et al.
Leukemia & Lymphoma|January 3, 2019
Mutation patterns in essential thrombocythemia, polycythemia vera and secondary myelofibrosisAnne Wanquet, Frédéric Courtier, Arnaud Guille, et al.
BMC Cancer|August 4, 2010
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemiasJulien Rocquain, Nadine Carbuccia, Virginie Trouplin, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Medicine|September 10, 2003
A further case of acute myelomonocytic leukemia with inv(8) chromosomal rearrangement and MOZ-NCOA2 gene fusionAnne Murati, José Adélaïde, Cornel Popovici, et al.
British Journal of Haematology|April 1, 2020
Gains of EPOR and ERG genes in adult erythroleukaemiaJosé Adélaïde, Nathalie Cervera, Arnaud Guille, et al.
American Journal of Hematology|March 6, 2014
Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemiaNathalie Cervera, Raphael Itzykson, Emilie Coppin, et al.
Haematologica|October 12, 2019
Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemiasNathalie Cervera, Anne-Catherine Lhoumeau, José Adélaïde, et al.
Haematologica|February 14, 2007
New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemiasAnne Murati, José Adélaïde, Benoît Quilichini, et al.
American Journal of Hematology|September 16, 2014
Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patientsRaynier Devillier, Véronique Gelsi-Boyer, Anne Murati, et al.
American Journal of Hematology|November 18, 2017
Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasmsGeoffroy Venton, Frédéric Courtier, Aude Charbonnier, et al.
Journal of Cell Science|March 24, 2005
NACA is a positive regulator of human erythroid-cell differentiationSophie Lopez, Laetitia Stuhl, Serge Fichelson, et al.
Leukemia & Lymphoma|January 3, 2019
Mutation patterns in essential thrombocythemia, polycythemia vera and secondary myelofibrosisAnne Wanquet, Frédéric Courtier, Arnaud Guille, et al.
BMC Cancer|August 4, 2010
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemiasJulien Rocquain, Nadine Carbuccia, Virginie Trouplin, et al.
Pageof 4